OSR Holdings, Inc. (OSRH)
OSR Holdings, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Bellevue, WA, US. The stock last traded at $0.37, down 4.74% on the session, giving a market capitalisation of $12.2M. On trailing twelve-month figures it carries a trailing P/E of -0.11, a net margin of -525.1%. Its beta of 0.57 implies it has historically moved less than the broad market.
OSR Holdings, Inc. operates as a Special Purpose Acquisition Company (SPAC) – essentially a blank check entity. Its primary objective is to execute a substantial business combination, which may take the form of a merger, a capital stock exchange, an asset acquisition, a stock purchase, a reorganization, or other comparable strategic transaction with one or more established businesses. The company was incorporated on February 25, 2020, and maintains its principal office in Bellevue, Washington.
OSR Holdings, Inc. is most often compared with the following Healthcare names: